76986-15-7

Basic information

• Product Name: 2-amino-2-(4-methoxyphenyl)acetamide
• Synonyms: 2-amino-2-(4-methoxyphenyl)acetamide
• CAS NO: 76986-15-7
• Molecular Weight: 180.206
• Mol File: 76986-15-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-amino-2-(4-methoxyphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-2-(4-methoxyphenyl)acetamide(76986-15-7)
• EPA Substance Registry System: 2-amino-2-(4-methoxyphenyl)acetamide(76986-15-7)

Safety Data

• Hazardous Substances Data: 76986-15-7(Hazardous Substances Data)

Usage

General Description

2-amino-2-(4-methoxyphenyl)acetamide, also known as memantine, is a medication used to treat moderate to severe Alzheimer's disease. It works by blocking the action of a neurotransmitter in the brain called glutamate, which is believed to be involved in the development and progression of Alzheimer's disease. Memantine is also used to treat dementia associated with Parkinson's disease and to reduce some of the symptoms of dementia, such as confusion and agitation. It is generally well-tolerated, with common side effects including dizziness, headache, and constipation. It is available in both oral and injectable formulations and is typically prescribed as part of a comprehensive treatment plan for Alzheimer's disease and other forms of dementia.

Upstream product

• 67-56-1 methanol 
• 2540-53-6 2-(4-methoxyphenyl)glycine 
• 33646-40-1 4-methoxymandelonitrile 
• 74273-47-5 methyl 2-amino-2-(4-methoxyphenyl)acetate 
• 13226-99-8 amino(3-chloro-4-methoxyphenyl)acetic acid methyl ester hydrochloride 

Downstream Products

• 931313-78-9 tert-butyl 2-(4-methoxyphenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-ene-8-carboxylate 
• 1108685-94-4 L-2-(2-methoxy-acetylamino)-2-(4-methoxyphenyl)-acetamide 
• 6617-78-3 5-(4-methoxyphenyl)imidazolidone-2,4-dione 
• 24593-48-4 (2S)-2-amino-2-(4-methoxyphenyl)acetic acid 
• 24593-49-5 D-(-)-2-(4-methoxyphenyl)glycine 
• 67412-96-8 D-(-)-4-methoxyphenylglycine amide 
• 96155-89-4 L-p-methoxyphenylglycine amide 
• 25084-42-8 C₉H₁₀Cl₂N₂O₂ 

Relevant articles and documents

EGFR DIMER DISRUPTORS AND USE OF THE SAME

Provided herein are compounds that modulate EGFR and methods of using the same, for example to treat cancer.

Glyt1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders

The invention provides a compound of formula (I) or a solvate thereof: wherein R1, R2, R3, R4, R5, R6, and n are as defined in the specification, and uses of such compounds. The compounds i

1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS

Novel acetophenone compounds of formula (I), compositions containing (I), processes for the preparation of (I), and use of (I) as inhibitors of the glycine transporter, are provided. Definitions of Ar, R5, R6, R7, R8